Evidence map›Paper›PMID 35865965›Full record

ArticleFrontiers in pharmacology2022

Qing`e Pill Inhibits Osteoblast Ferroptosis

Jian Hao, Jiaxin Bei, Zhenhan Li, Mingyuan Han, Boyuan Ma, Pengyi Ma, Xianhu Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Investigating the Osteoregenerative Properties ofJournal of functional biomaterials · 2025
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. FructusBiomedical reports · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jian HaoOrthopedics Department, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
Jiaxin BeiLaboratory of Interventional Radiology, Department of Minimally Invasive Interventional Radiology and Department of Radiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhenhan LiSchool of Clinical, Wannan Medical College, Wuhu, China.
Mingyuan HanOrthopedics Department, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
Boyuan MaOrthopedics Department, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
Pengyi MaDepartment of Orthopaedic, Graduate School, Tianjin Medical University, Tianjin, China.
Xianhu ZhouOrthopedics Department, The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China.
Ningbo University · CNGuangzhou Medical University · CNTianjin Medical University · CNWannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis (OP) is an aging-related disease that is the main etiology of fragility fracture. Qing'e Pill (QEP) is a mixture of traditional Chinese medicine (TCM) consisting of

Indexed as

ATMferroptosisnetwork analysisosteoporosisPI3K/AKT pathwayQing'e Pill

Identifiers

PMID35865965
PMCPMC9294279
OpenAlexW4283815346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.